These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 8097823

  • 1. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers.
    Lo YM, Bowell PJ, Selinger M, Mackenzie IZ, Chamberlain P, Gillmer MD, Littlewood TJ, Fleming KA, Wainscoat JS.
    Lancet; 1993 May 01; 341(8853):1147-8. PubMed ID: 8097823
    [No Abstract] [Full Text] [Related]

  • 2. Non-invasive antenatal diagnosis.
    Gaudoin MR.
    Lancet; 1993 Jul 03; 342(8862):54-5. PubMed ID: 8100327
    [No Abstract] [Full Text] [Related]

  • 3. Prenatal determination of fetal rhesus D status by DNA amplification of peripheral blood of rhesus-negative mothers.
    Lo YM, Bowell PJ, Selinger M, Mackenzie IZ, Chamberlain P, Gillmer MD, Elliott P, Pratt G, Littlewood TJ, Fleming KA.
    Ann N Y Acad Sci; 1994 Sep 07; 731():229-36. PubMed ID: 7944125
    [Abstract] [Full Text] [Related]

  • 4. Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi.
    Fisk NM, Bennett P, Warwick RM, Letsky EA, Welch R, Vaughan JI, Moore G.
    Am J Obstet Gynecol; 1994 Jul 07; 171(1):50-4. PubMed ID: 8030733
    [Abstract] [Full Text] [Related]

  • 5. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
    Moussa H, Tsochandaridis M, Jemni-Yacoub S, Hmida S, Khairi H, Gabert J, Levy-Mozziconacci A.
    Ann Biol Clin (Paris); 2012 Jul 07; 70(6):683-8. PubMed ID: 23207814
    [Abstract] [Full Text] [Related]

  • 6. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
    Cortey A, Brossard Y, Beliard R, Bourel D.
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb 07; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
    [Abstract] [Full Text] [Related]

  • 7. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease.
    Le Van Kim C, Mouro I, Brossard Y, Chavinié J, Cartron JP, Colin Y.
    Br J Haematol; 1994 Sep 07; 88(1):193-5. PubMed ID: 7803243
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prenatal determination of fetal RhD type by DNA amplification.
    Bennett PR, Le Van Kim C, Colin Y, Warwick RM, Chérif-Zahar B, Fisk NM, Cartron JP.
    N Engl J Med; 1993 Aug 26; 329(9):607-10. PubMed ID: 8341334
    [Abstract] [Full Text] [Related]

  • 10. Noninvasive fetal Rh genotyping: the time has come.
    Queenan JT.
    Obstet Gynecol; 2005 Oct 26; 106(4):682-3. PubMed ID: 16199621
    [No Abstract] [Full Text] [Related]

  • 11. Fetal RhD genotyping from maternal plasma.
    Lo YM.
    Ann Med; 1999 Oct 26; 31(5):308-12. PubMed ID: 10574502
    [Abstract] [Full Text] [Related]

  • 12. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.
    Rouillac-Le Sciellour C, Puillandre P, Gillot R, Baulard C, Métral S, Le Van Kim C, Cartron JP, Colin Y, Brossard Y.
    Mol Diagn; 2004 Oct 26; 8(1):23-31. PubMed ID: 15230639
    [Abstract] [Full Text] [Related]

  • 13. Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells.
    Lighten AD, Overton TG, Sepulveda W, Warwick RM, Fisk NM, Bennett PR.
    Am J Obstet Gynecol; 1995 Oct 26; 173(4):1182-5. PubMed ID: 7485316
    [Abstract] [Full Text] [Related]

  • 14. [Noninvasive prenatal diagnosis from maternal plasma in serological conflicts in Poland: current practice and future prospects].
    Orzińska A, Guz K, Brojer E.
    Ginekol Pol; 2009 Oct 26; 80(10):768-71. PubMed ID: 19943542
    [Abstract] [Full Text] [Related]

  • 15. [Prenatal determination of fetal RHD in maternal plasma: two-years experience of routine clinical use].
    Minon JM, Schaaps JP, Retz MC, Dricot JF, Foidart JM, Senterre JM.
    J Gynecol Obstet Biol Reprod (Paris); 2005 Sep 26; 34(5):448-53. PubMed ID: 16142135
    [Abstract] [Full Text] [Related]

  • 16. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
    Scheffer PG, van der Schoot CE, Page-Christiaens GC, de Haas M.
    BJOG; 2011 Oct 26; 118(11):1340-8. PubMed ID: 21668766
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.
    Bianchi DW, Avent ND, Costa JM, van der Schoot CE.
    Obstet Gynecol; 2005 Oct 26; 106(4):841-4. PubMed ID: 16199645
    [Abstract] [Full Text] [Related]

  • 18. Non invasive prenatal determination of fetal rhesus d status from maternal plasma: need of the time for Pakistan.
    Mohammad N.
    J Coll Physicians Surg Pak; 2006 Aug 26; 16(8):564. PubMed ID: 16899194
    [No Abstract] [Full Text] [Related]

  • 19. RhD hemolytic disease of the newborn.
    Bowman JM.
    N Engl J Med; 1998 Dec 10; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract] [Full Text] [Related]

  • 20. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
    Hromadnikova I, Vesela K, Benesova B, Nekovarova K, Duskova D, Vlk R, Spalova I, Gerychova R, Hakenova A, Rosenbaumova Z, Vlasin P, Vlachova A, Palasek V, Roznakova E, Calda P.
    Prenat Diagn; 2005 Dec 10; 25(12):1079-83. PubMed ID: 16231295
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.